⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘T-cell lymphoma of the skin✘Measles
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 96%(17)100%(15)
ECG 55%(0)65%(0)
Blood biochemistry 100%(4)18%(1)
General urine test 55%(5)61%(4)
Coagulogram 88%(2)28%(1)
MRI of the brain 38%(0)29%(0)
Histological studies 34%(0)32%(0)
Infection tests 14%(1)49%(2)
Chest radiography 30%(0)8%(0)
Ophthalmologist's examination 34%(0)—
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 44%—
Register, to see more distinctive signs of diseases and studies —71%
increased ldh 43% —
nasal congestion lying down — 69%
increased ferritin 42% —
chickenpox — 55%
skin lymphoma 39% —
bad breath unpleasant — 51%
non-Hodgkin's lymphoma 39% —
papillomas on the neck — 50%
with reactive protein increased 36% —
measles antibodies — 49%
fungal mycosis 35% —
bruises under the eyes — 49%
cesari syndrome 34% —
tooth decay — 47%
erythroderma 34% —
sneezing in the morning — 46%
lymphoma 33% —
is better when busy — 43%
protein with increased 32% —
dry skin — 42%
malignant lymphoma 32% —
hypersensitivity to cold — 40%
carcinoid 31% —
runny nose — 39%
acrogeria familial 31% —
better from cold — 39%
basal 31% —
impatient — 38%
epithelioma 30% —
vaccination 14% 51%
leukemia 30% —
jealous — 37%
serious condition 38% 6%
subacute sclerosing panencephalitis — 36%
lymphosarcoma 29% —
likes sweets — 36%
lymphomas in children 28% —
often sneezes — 36%
burkitt's lymphoma 26% —
nasal congestion — 35%
fungus 25% —
red rash 22% 55%
follicular mucinosis 24% —
rash on the body — 33%
cancer 24% —
chatty — 33%
hair loss 24% —
dark eyes — 32%
allgrove syndrome 24% —
measles — 32%
bald 24% —
rubella — 31%
itchy skin 23% —
adenoids — 30%
baldness 22% —
rash on the cheeks — 30%
skin problems 27% 3%
disease from experiences — 30%
oncology 27% 4%
illness from distress — 30%
neuroleukosis 21% —
consequences of measles — 29%
skin atrophy 21% —
dry skin of the face — 29%
dermographism white 20% —
enlarged lymph nodes of the neck — 28%
acute leukemia 20% —
pale face — 28%
hypotrophy 20% —
rashes on the face — 27%
increased ESR 34% 12%
swelling of eyelids — 27%
oily skin 19% —
transparent snot — 27%
patient's condition is satisfactory 18% —
green discharge from the nose abundant — 26%
cns lymphoma 18% —
green mucus from the nose — 26%
the surface is smooth 18% —
conjunctivitis purulent — 26%
acute renal failure 18% —
indecision — 25%
dry hair falls 18% —
daytime fever — 25%
pitiriasis 18% —
dry 10% 35%
thin 18% —
mucus in the nose — 25%
cns tumors 18% —
chronic condition — 25%
parapsoriasis 18% —
heavy mucus in the nose — 25%
lymph node damage 18% —
rashes behind the ears — 25%
pleurisy 18% —
cough — 24%
positive 18% —
sputum copious — 23%
oncology in the anamnesis 17% —
rash in the mouth — 23%
risk ii 17% —
mucous hyperemia — 23%
radiation damage to the nervous system 17% —
brown spots on the skin — 23%
tumor collapse syndrome 17% —
dryness of the nasal mucosa — 23%
kidney failure 17% —
brown pigmentation after rashes — 23%
patient's condition 37% 18%
nasal discharge purulent — 22%
palms yellow 16% —
conjunctivitis — 22%
erection at night 16% —
green discharge from the nose — 22%
mediastinal tumors 16% —
mucous discharge from the nose — 22%
appendicitis 16% —
rashes on the palate — 21%
scales on the head 16% —
rashes on the shoulders — 21%
sarcoidosis of the skin 16% —
photophobia — 21%
down focal baldness 16% —
sputum — 21%
ollier 's disease 16% —
vaccinations according to the plan — 21%
a history of organ transplantation 16% —
worse in morning — 21%
pain in the lymph nodes 16% —
swelling of the throat — 21%
problematic skin 16% —
sputum green — 21%
radiation damage 16% —
decrease in ESR — 20%
red lichen planus 16% —
encephalitis — 20%
focal hair loss 16% —
abundance of mucus — 20%
vascular tumor 16% —
lymphocytosis — 20%
tumors of the sebaceous glands 15% —
recovery period — 20%
for an increase in ige 15% —
laryngotracheitis — 20%
mediastinal cancer 15% —
dryness in the nose — 20%
control issues 15% —
rash on the limbs — 20%
onychodystrophy 15% —
stage of recovery — 20%
monocytosis 15% —
severe dryness in the nose — 19%
hemophagocytic syndrome 15% —
dry cough — 19%
heaviness in the right side 15% —
red lips dry — 19%
hydrothorax 15% —
subfebrility — 19%
liver problems 15% —
rashes red spots — 18%
tumour in the abdomen 15% —
tracheitis — 18%
chronic eczema 15% —
gums are red — 18%
no knots 15% —
slow cns infections — 18%
saliuria 14% —
crackling when breathing — 18%
dermatomycosis 14% —
nose swelling — 18%
lichen 14% —
red spots on the skin — 18%
intestinal tumor 14% —
transparent snot during the day — 18%
consequences of surgery 14% —
gums white — 18%
acute appendicitis 14% —
epidemic encephalitis — 18%
red palms 14% —
cough dry day — 17%
red hands 14% —
cough from snot — 17%
rashes on the palms 14% —
rapid breathing — 17%
peptic ulcer 14% —
crackling in the lungs — 17%
ascites 14% —
laryngitis — 17%
exhaustion after illness 14% —
copious discharge from the nose — 16%
heaviness in the kidneys 14% —
transparent sputum — 16%
head tumor 14% —
neutropenia — 16%
impaired kidney function 14% —
cervical lymphadenitis — 16%
hemorrhagic cystitis 14% —
acute laryngeal stenosis — 16%
metabolic disorder 14% —
hyperemia of the nasal mucosa — 16%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.